Hims & Hers Appoints New CMO, Adds Directors

TL;DR

Hims & Hers shakes up leadership: new CMO in, old CMO out, two new board members elected.

AI Summary

Hims & Hers Health, Inc. announced on July 16, 2024, the appointment of Dr. Melissa Byington as Chief Medical Officer and the departure of Dr. Patrick Carroll from the same role. Dr. Byington's appointment is effective immediately, and she will also serve as a member of the company's executive leadership team. The company also announced the election of two new directors, Dr. David Rosenberg and Ms. Sarah McCombie, to its Board of Directors.

Why It Matters

Changes in key executive and board positions can signal shifts in company strategy or operational focus, potentially impacting future performance and investor confidence.

Risk Assessment

Risk Level: medium — Changes in executive and board leadership can introduce uncertainty regarding future strategy and execution.

Key Players & Entities

• Hims & Hers Health, Inc. (company) — Registrant
• Dr. Melissa Byington (person) — Appointed Chief Medical Officer
• Dr. Patrick Carroll (person) — Departed Chief Medical Officer
• Dr. David Rosenberg (person) — Elected Director
• Ms. Sarah McCombie (person) — Elected Director
• July 16, 2024 (date) — Date of earliest event reported

FAQ

From the Filing

0001773751-24-000230.txt : 20240722 0001773751-24-000230.hdr.sgml : 20240722 20240722163522 ACCESSION NUMBER: 0001773751-24-000230 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240716 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240722 DATE AS OF CHANGE: 20240722 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 241131915 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 8-K 1 hims-20240716.htm 8-K hims-20240716 0001773751 false 0001773751 2024-07-15 2024-07-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________________________________________________ FORM  8-K _____________________________________________________________________________________________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2024 _____________________________________________________________________________________________________________________ HIMS & HERS HEALTH, INC. (Exact name of registrant as specified in its charter) _____________________________________________________________________________________________________________________ Delaware   001-38986   98-1482650 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 2269 Chestnut Street, #523 San Francisco , CA 94123 (Address of principal executive offices) ( 415 ) 851-0195 (Registrant’s telephone number, including area code) ______________________________________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Class A Common Stock, $0.0001 par value   HIMS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).  Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 5.02 Departure of Direc